Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 4,444,423,600
  • Market Capitalization, $K 4,444,424
  • Shares Outstanding, K 51,150
  • 60-Month Beta 1.71
  • Price/Earnings ttm 15.72
  • Annual Dividend & Yield 0.09 (0.10%)
  • Most Recent Dividend 0.012 on 12/21/18
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.31 +6.97%
on 05/31/19
88.77 -4.43%
on 06/20/19
+1.93 (+2.33%)
since 05/24/19
3-Month
79.31 +6.97%
on 05/31/19
93.87 -9.62%
on 04/05/19
-3.02 (-3.44%)
since 03/22/19
52-Week
64.38 +31.78%
on 12/24/18
101.17 -16.14%
on 07/09/18
-14.24 (-14.37%)
since 06/22/18

Most Recent Stories

More News
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.40 (-2.28%)
CELG : 93.47 (-5.50%)
ILMN : 357.74 (-1.06%)
IBB : 107.12 (-2.13%)
QGEN : 40.68 (-0.07%)
XBI : 84.73 (-2.90%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.40 (-2.28%)
CELG : 93.47 (-5.50%)
ILMN : 357.74 (-1.06%)
ALNY : 71.80 (-3.46%)
FBT : 137.49 (-1.76%)
XBI : 84.73 (-2.90%)
S&P 500 Hit New Records: Buy These High-Beta ETFs & Stocks

High-beta ETFs & stocks seek to capitalize on continued growth with market-beating returns.

RNGR : 6.98 (+4.18%)
PTF : 73.33 (-1.24%)
KO : 51.92 (+0.72%)
TWTR : 35.58 (+1.60%)
VTWG : 143.25 (-1.46%)
PXMG : 59.49 (-1.10%)
OMF : 32.03 (-2.26%)
FXZ : 37.47 (-0.49%)
DXPE : 35.88 (-2.34%)
AVID : 8.49 (-1.74%)
LMT : 359.98 (+0.17%)
UTX : 130.18 (+1.11%)
NCR : 30.78 (+0.13%)
XBI : 84.73 (-2.90%)
S&P 500 Hit New Records: Buy These High-Beta ETFs & Stocks

High-beta ETFs & stocks seek to capitalize on continued growth with market-beating returns.

RNGR : 6.98 (+4.18%)
PTF : 73.33 (-1.24%)
KO : 51.92 (+0.72%)
TWTR : 35.58 (+1.60%)
VTWG : 143.25 (-1.46%)
PXMG : 59.49 (-1.10%)
OMF : 32.03 (-2.26%)
FXZ : 37.47 (-0.49%)
DXPE : 35.88 (-2.34%)
AVID : 8.49 (-1.74%)
LMT : 359.98 (+0.17%)
UTX : 130.18 (+1.11%)
NCR : 30.78 (+0.13%)
XBI : 84.73 (-2.90%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 52.40 (-2.28%)
CELG : 93.47 (-5.50%)
ILMN : 357.74 (-1.06%)
IBB : 107.12 (-2.13%)
ALNY : 71.80 (-3.46%)
XBI : 84.73 (-2.90%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

BBP : 40.49 (-1.65%)
SBIO : 35.15 (-2.31%)
ARKG : 31.85 (-2.45%)
ONCE : 101.91 (-3.01%)
ILMN : 357.74 (-1.06%)
JNJ : 143.06 (+0.68%)
LLY : 115.63 (+0.12%)
NVS : 92.80 (+0.34%)
RHHBY : 35.3850 (-0.60%)
PFE : 43.76 (+0.21%)
XBI : 84.73 (-2.90%)
BTEC : 33.39 (-0.91%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

BBP : 40.49 (-1.65%)
SBIO : 35.15 (-2.31%)
ARKG : 31.85 (-2.45%)
ONCE : 101.91 (-3.01%)
ILMN : 357.74 (-1.06%)
JNJ : 143.06 (+0.68%)
LLY : 115.63 (+0.12%)
NVS : 92.80 (+0.34%)
RHHBY : 35.3850 (-0.60%)
PFE : 43.76 (+0.21%)
XBI : 84.73 (-2.90%)
BTEC : 33.39 (-0.91%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

CELG : 93.47 (-5.50%)
VHT : 174.20 (-0.64%)
XLV : 93.24 (-0.52%)
ONCE : 101.91 (-3.01%)
NITE : 25.41 (-0.04%)
BBH : 125.78 (-1.77%)
BMY : 45.68 (-7.42%)
BTEC : 33.39 (-0.91%)
LLY : 115.63 (+0.12%)
FBT : 137.49 (-1.76%)
IYH : 196.35 (-0.51%)
GSK : 40.59 (+0.79%)
XBI : 84.73 (-2.90%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

CELG : 93.47 (-5.50%)
VHT : 174.20 (-0.64%)
XLV : 93.24 (-0.52%)
ONCE : 101.91 (-3.01%)
NITE : 25.41 (-0.04%)
BBH : 125.78 (-1.77%)
BMY : 45.68 (-7.42%)
BTEC : 33.39 (-0.91%)
LLY : 115.63 (+0.12%)
FBT : 137.49 (-1.76%)
IYH : 196.35 (-0.51%)
GSK : 40.59 (+0.79%)
XBI : 84.73 (-2.90%)
A Spread of Top-Ranked ETFs That Crushed the Market in Q1

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.

BBP : 40.49 (-1.65%)
PGJ : 36.91 (-0.35%)
ASHR : 28.29 (+1.11%)
PTF : 73.33 (-1.24%)
PXMG : 59.49 (-1.10%)
KBA : 31.09 (+0.65%)
ASHX : 20.07 (+0.55%)
XSW : 95.55 (-1.36%)
XBI : 84.73 (-2.90%)
BTEC : 33.39 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 88.53
1st Resistance Point 87.90
Last Price 84.73
1st Support Level 85.99
2nd Support Level 84.71

See More

52-Week High 101.17
Fibonacci 61.8% 87.12
Last Price 84.73
Fibonacci 50% 82.77
Fibonacci 38.2% 78.43
52-Week Low 64.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar